Search - tctmd.com

Displaying 361 - 380 of 740

Sort: Relevancy | Date

Presentation TCT 2019

Clinical Rationale for LAA Closure After AF Ablation

Presenter: DJ Lakkireddy

September 26, 2019

Presentation TCT 2019

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Presenter: Brian Whisenant

September 26, 2019

Presentation TCT 2019

LAA Closure in the United States: Update From the NCDR LAAO Registry

Presenter: Matthew Price

September 26, 2019

Presentation TCT 2019

AMULET: Device Characteristics, Procedural Technique, Clinical Outcomes, and Ongoing Studies

Presenter: James Hermiller

September 26, 2019

Presentation TCT 2019

WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX

Presenter: Saibal Kar

September 26, 2019

Presentation TCT 2019

LAA Closure vs. NOACs: Pros and Cons, PRAGUE 17, and Additional Trials

Presenter: Vivek Reddy

September 26, 2019

Presentation TCT 2019

Patient Selection for LAA Closure: Risk Prediction Beyond CHA(2)DS(2)VASc and HAS-BLED

Presenter: Edip Gurol

September 26, 2019

Presentation TCT 2019

Second-Generation LAA Occlusion: Single-Size and Conforming to a Broad Range of Anatomies (Conformal Medical)

Presenter: William Gray

September 25, 2019

Presentation TCT 2019

TCT 116: Peri-device leaks following transcatheter left atrial appendage occlusion with the Amplatzer devices: Correlation between cardiac CT and transesophageal echocardiography

Presenter: Kasper Korsholm

September 25, 2019

Presentation TCT 2019

TCT 115: The novel Watchman FLX for left atrial appendage closure. Early European experience.

Presenter: Jens Erik Nielsen-Kudsk

September 25, 2019

Presentation TCT 2019

TCT 114: Comparative Data on Left Atrial Appendage Occlusion Efficacy and Clinical Outcomes by Age Group in the Amplatzer Amulet Observational Study

Presenter: Xavier Freixa

September 25, 2019

Presentation TCT 2019

TCT 113: Adverse Events after Left Atrial Appendage Closure: Lessons Learned from the Manufacturer and User Facility Device Experience (MAUDE) database.

Presenter: Swaiman Singh

September 25, 2019

Presentation TCT 2019

Case 10 (From Taiwan): A Challenging LAA Closure

Presenter: Ying-Hsiang Lee

September 25, 2019

Presentation TCT 2019

Learn the Technique (Case-Based): LAA Closure

Presenter: Alexey Protopopov

September 25, 2019

Presentation TCT 2019

Left Atrial Appendage Closure: A Congenital Skill for a Non-Congenital Disease

Presenter: Horst Sievert

September 25, 2019

News Daily News

Surgical Bailout Rarely Needed Though Can Save Lives: TVT Registry

Yael L. Maxwell

September 18, 2019

News Conference News ESC 2019

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

Todd Neale

September 11, 2019

News Conference News ESC 2019

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

Todd Neale

September 10, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for August 2019

Shelley Wood

August 30, 2019

News Daily News

Late Follow-up of Surgical MV Repair: Insights for Timing, Innovation

Shelley Wood

August 20, 2019

Advertisement

Clinical Rationale for LAA Closure After AF Ablation

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

LAA Closure in the United States: Update From the NCDR LAAO Registry

AMULET: Device Characteristics, Procedural Technique, Clinical Outcomes, and Ongoing Studies

WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX

LAA Closure vs. NOACs: Pros and Cons, PRAGUE 17, and Additional Trials

Patient Selection for LAA Closure: Risk Prediction Beyond CHA(2)DS(2)VASc and HAS-BLED

Second-Generation LAA Occlusion: Single-Size and Conforming to a Broad Range of Anatomies (Conformal Medical)

TCT 116: Peri-device leaks following transcatheter left atrial appendage occlusion with the Amplatzer devices: Correlation between cardiac CT and transesophageal echocardiography

TCT 115: The novel Watchman FLX for left atrial appendage closure. Early European experience.

TCT 114: Comparative Data on Left Atrial Appendage Occlusion Efficacy and Clinical Outcomes by Age Group in the Amplatzer Amulet Observational Study

TCT 113: Adverse Events after Left Atrial Appendage Closure: Lessons Learned from the Manufacturer and User Facility Device Experience (MAUDE) database.

Case 10 (From Taiwan): A Challenging LAA Closure

Learn the Technique (Case-Based): LAA Closure

Left Atrial Appendage Closure: A Congenital Skill for a Non-Congenital Disease

Surgical Bailout Rarely Needed Though Can Save Lives: TVT Registry

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

TCTMD’s Top 10 Most Popular Stories for August 2019

Late Follow-up of Surgical MV Repair: Insights for Timing, Innovation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content